Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Cell Rep ; 43(1): 113662, 2024 01 23.
Article in English | MEDLINE | ID: mdl-38184854

ABSTRACT

TDP-43 is an RNA/DNA-binding protein that forms aggregates in various brain disorders. TDP-43 engages in many aspects of RNA metabolism, but its molecular roles in regulating genes and transposable elements (TEs) have not been extensively explored. Chronic TDP-43 knockdown impairs cell proliferation and cellular responses to DNA damage. At the molecular level, TDP-43 chronic deficiency affects gene expression either locally or distally by concomitantly altering the crosstalk between R-loops and 5-hydroxymethylcytosine (5hmC) in gene bodies and long-range enhancer/promoter interactions. Furthermore, TDP-43 knockdown induces substantial disease-relevant TE activation by influencing their R-loop and 5hmC homeostasis in a locus-specific manner. Together, our findings highlight the genomic roles of TDP-43 in modulating R-loop-5hmC coordination in coding genes, distal regulatory elements, and TEs, presenting a general and broad molecular mechanism underlying the contributions of proteinopathies to the etiology of neurodegenerative disorders.


Subject(s)
DNA Transposable Elements , R-Loop Structures , DNA Transposable Elements/genetics , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , RNA/metabolism , Gene Expression
2.
Proc Natl Acad Sci U S A ; 119(50): e2214988119, 2022 12 13.
Article in English | MEDLINE | ID: mdl-36469784

ABSTRACT

The mechanisms by which environmentally-induced epiphenotypes are transmitted transgenerationally in mammals are poorly understood. Here we show that exposure of pregnant mouse females to bisphenol A (BPA) results in obesity in the F2 progeny due to increased food intake. This epiphenotype can be transmitted up to the F6 generation. Analysis of chromatin accessibility in sperm of the F1-F6 generations reveals alterations at sites containing binding motifs for CCCTC-binding factor (CTCF) at two cis-regulatory elements (CREs) of the Fto gene that correlate with transmission of obesity. These CREs show increased interactions in sperm of obese mice with the Irx3 and Irx5 genes, which are involved in the differentiation of appetite-controlling neurons. Deletion of the CTCF site in Fto results in mice that have normal food intake and fail to become obese when ancestrally exposed to BPA. The results suggest that epigenetic alterations of Fto can lead to the same phenotypes as genetic variants.


Subject(s)
CCCTC-Binding Factor , Epigenesis, Genetic , Obesity , Semen , Animals , Female , Male , Mice , Pregnancy , Alpha-Ketoglutarate-Dependent Dioxygenase FTO/genetics , Benzhydryl Compounds/toxicity , Heredity , Obesity/chemically induced , Obesity/genetics , CCCTC-Binding Factor/metabolism
3.
Phlebology ; 37(3): 216-222, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35236191

ABSTRACT

BACKGROUND: Catheter-directed thrombolysis (CDT) is one of the main treatment methods for acute deep venous thrombosis (DVT), which has the characteristics of long treatment time and large dosage of thrombolytic drugs. In the absence of good monitoring methods, problems such as low thrombolytic efficiency and high risk of bleeding are easy to occur. OBJECTIVE: To evaluate the value of D-dimer (D-D) and fibrinogen (FIB) testing as a thrombolysis-monitoring method during CDT for acute DVT. METHODS: Twenty patients with acute DVT were divided into group A and group B. During CDT, the D-D and FIB testing every 8 h were used in group A, and the venography and FIB testing every 24 h in group B. The thrombolysis rate, thrombolysis time, urokinase dosage, and X-ray radiation dose were compared. RESULTS: The thrombolysis rate in group A was significantly higher than that in group B (p < 0.05), but the number of venography and radiation dose were significantly lower than those in group B (p < 0.05). CONCLUSION: D-D and FIB testing can improve the thrombolysis rate, reduce the risk of bleeding, and decrease the number of angiograms and X-ray radiation dose during CDT.


Subject(s)
Thrombolytic Therapy , Venous Thrombosis , Catheters , Fibrin Fibrinogen Degradation Products , Fibrinolytic Agents , Humans , Thrombolytic Therapy/methods , Treatment Outcome , Venous Thrombosis/diagnostic imaging , Venous Thrombosis/drug therapy
4.
Curr Opin Genet Dev ; 67: 33-40, 2021 04.
Article in English | MEDLINE | ID: mdl-33259986

ABSTRACT

Studies of nuclear architecture using chromosome conformation capture methods have provided a detailed view of how chromatin folds in the 3D nuclear space. New variants of this technology now afford unprecedented resolution and allow the identification of ever smaller folding domains that offer new insights into the mechanisms by which this organization is established and maintained. Here we review recent results in this rapidly evolving field with an emphasis on CTCF function, with the goal of gaining a mechanistic understanding of the principles by which chromatin is folded in the eukaryotic nucleus.


Subject(s)
CCCTC-Binding Factor/genetics , Cell Nucleus/ultrastructure , Chromatin/ultrastructure , Chromosomes/ultrastructure , Animals , Cell Nucleus/genetics , Chromatin/genetics , Chromosomes/genetics , Humans
5.
Kaohsiung J Med Sci ; 36(5): 363-370, 2020 May.
Article in English | MEDLINE | ID: mdl-31943723

ABSTRACT

Recurrent pregnancy loss (RPL) is three or more times of consecutive spontaneous loss of pregnancy. The underlying cause is complicated and the etiology of over 50% of RPL patients is unclear. In the present study, bone marrow mesenchymal stem cells were isolated from CBA/J female mice and exosomes were isolated from cell culture medium by ultracentrifugation. CBA/J female mice were paired with male DBA/2 to generate abortion prone mouse model, and CBA/J females paired with male BALB/c mice were used as control. Exosomes were injected through uterine horns into pregnant CBA/J mice on day 4.5 of gestation in abortion-prone matting. On day 13.5 of pregnancy, abortion rates were calculated and the level of transforming growth factor-ß (TGF-ß), interleukin 10 (IL-10), interferon g (IFN-γ), and tumor necrosis factor a (TNF-α) in CD4+ T cells and macrophages in deciduas were evaluated by flow cytometry. Exosomes injection improved the pregnancy outcomes in abortion prone mice. The IL-4 and IL-10 levels on CD4+ T cells were upregulated in the maternal-fetal interface; meanwhile, the TNF-α and IFN-γ levels on CD4+ T cells were reduced. The IL-10 level was increased and IL-12 was reduced on the monocytes that separated from deciduas. miR-101 level was increased in the CD4+ T cells in the deciduas. In conclusion, the treatment of ESCs-derived exosomes modulates T cells' function and macrophages activities in the maternal-fetal interface that resulted in a decreased embryo resorption rate, and provides a therapeutic potential to treat RPL.


Subject(s)
Abortion, Habitual/immunology , Exosomes/metabolism , Fetus/immunology , Immune Tolerance , Mesenchymal Stem Cells/metabolism , Pregnancy Outcome , Sexual Behavior, Animal , Abortion, Habitual/genetics , Animals , Female , Immunophenotyping , Macrophages/metabolism , Maternal-Fetal Exchange , Mice , MicroRNAs/genetics , MicroRNAs/metabolism , Pregnancy , T-Lymphocytes/metabolism
6.
Mol Cell ; 69(1): 126-135.e6, 2018 01 04.
Article in English | MEDLINE | ID: mdl-29304330

ABSTRACT

N6-methyladenosine (m6A) and adenosine-to-inosine (A-to-I) editing are two of the most abundant RNA modifications, both at adenosines. Yet, the interaction of these two types of adenosine modifications is largely unknown. Here we show a global A-to-I difference between m6A-positive and m6A-negative RNA populations. Both the presence and extent of A-to-I sites in m6A-negative RNA transcripts suggest a negative correlation between m6A and A-to-I. Suppression of m6A-catalyzing enzymes results in global A-to-I RNA editing changes. Further depletion of m6A modification increases the association of m6A-depleted transcripts with adenosine deaminase acting on RNA (ADAR) enzymes, resulting in upregulated A-to-I editing on the same m6A-depleted transcripts. Collectively, the effect of m6A on A-to-I suggests a previously underappreciated interplay between two distinct and abundant RNA modifications, highlighting a complex epitranscriptomic landscape.


Subject(s)
Adenosine/analogs & derivatives , Adenosine/chemistry , Inosine/chemistry , RNA Editing/genetics , RNA/genetics , Adenosine Deaminase/genetics , Adenosine Deaminase/metabolism , Cell Line, Tumor , Gene Expression Regulation/genetics , HEK293 Cells , HeLa Cells , Humans , Methyltransferases/genetics , Methyltransferases/metabolism , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism
7.
Cell Discov ; 3: 16050, 2017.
Article in English | MEDLINE | ID: mdl-28163927

ABSTRACT

Protein translation regulation has essential roles in inflammatory responses, cancer initiation and the pathogenesis of several neurodegenerative disorders. However, the role of the regulation of protein translation in mammalian skeleton development has been rarely elaborated. Here we report that the lack of the RNA-binding protein sterile alpha motif domain containing protein 4 (SAMD4) resulted in multiple developmental defects in mice, including delayed bone development and decreased osteogenesis. Samd4-deficient mesenchymal progenitors exhibit impaired osteoblast differentiation and function. Mechanism study demonstrates that SAMD4 binds the Mig6 mRNA and inhibits MIG6 protein synthesis. Consistent with this, Samd4-deficient cells have increased MIG6 protein level and knockdown of Mig6 rescues the impaired osteogenesis in Samd4-deficient cells. Furthermore, Samd4-deficient mice also display chondrocyte defects, which is consistent with the regulation of MIG6 protein level by SAMD4. These findings define SAMD4 as a previously unreported key regulator of osteoblastogenesis and bone development, implying that regulation of protein translation is an important mechanism governing skeletogenesis and that control of protein translation could have therapeutic potential in metabolic bone diseases, such as osteoporosis.

8.
Mol Cell ; 64(3): 534-548, 2016 11 03.
Article in English | MEDLINE | ID: mdl-27871485

ABSTRACT

We identify a type of polycistronic transcript-derived long noncoding RNAs (lncRNAs) that are 5' small nucleolar RNA (snoRNA) capped and 3' polyadenylated (SPAs). SPA processing is associated with nascent mRNA 3' processing and kinetic competition between XRN2 trimming and Pol II elongation. Following cleavage/polyadenylation of its upstream gene, the downstream uncapped pre-SPA is trimmed by XRN2 until this exonuclease reaches the co-transcriptionally assembled snoRNP. This snoRNP complex prevents further degradation, generates a snoRNA 5' end, and allows continuous Pol II elongation. The imprinted 15q11-q13 encodes two SPAs that are deleted in Prader-Willi syndrome (PWS) patients. These lncRNAs form a nuclear accumulation that is enriched in RNA binding proteins (RBPs) including TDP43, RBFOX2, and hnRNP M. Generation of a human PWS cellular model by depleting these lncRNAs results in altered patterns of RBPs binding and alternative splicing. Together, these results expand the diversity of lncRNAs and provide additional insights into PWS pathogenesis.


Subject(s)
Base Sequence , Prader-Willi Syndrome/genetics , RNA, Long Noncoding/genetics , RNA, Small Nucleolar/genetics , Sequence Deletion , Transcription, Genetic , Alternative Splicing , Chromosomes, Human, Pair 15 , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Exoribonucleases/genetics , Exoribonucleases/metabolism , Genetic Loci , Genomic Imprinting , Heterogeneous-Nuclear Ribonucleoprotein Group M/genetics , Heterogeneous-Nuclear Ribonucleoprotein Group M/metabolism , Human Embryonic Stem Cells/metabolism , Human Embryonic Stem Cells/pathology , Humans , Prader-Willi Syndrome/metabolism , Prader-Willi Syndrome/pathology , Protein Binding , RNA Polymerase II/genetics , RNA Polymerase II/metabolism , RNA Splicing Factors/genetics , RNA Splicing Factors/metabolism , RNA, Long Noncoding/metabolism , RNA, Small Nucleolar/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism
9.
Curr Opin Genet Dev ; 33: 41-8, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26254776

ABSTRACT

Aberrant expression of long noncoding RNAs (lncRNAs) has been linked to cancers. The MYC oncoprotein is a key contributor to the development of many human tumors. Recent studies have revealed that a number of lncRNAs originating from the human 8q24 locus previously known to corresponding to a 'gene desert' are transcribed and play important roles in MYC regulation. In this review, we highlight recent progress in how these lncRNAs participate in control of MYC levels in normal and tumor cells.


Subject(s)
Neoplasms/genetics , Proto-Oncogene Proteins c-myc/genetics , RNA, Long Noncoding/genetics , Gene Expression Regulation, Neoplastic , Humans , Neoplasms/pathology
10.
Genes Dev ; 29(6): 630-45, 2015 Mar 15.
Article in English | MEDLINE | ID: mdl-25792598

ABSTRACT

In many cells, mRNAs containing inverted repeated Alu elements (IRAlus) in their 3' untranslated regions (UTRs) are inefficiently exported to the cytoplasm. Such nuclear retention correlates with paraspeckle-associated protein complexes containing p54(nrb). However, nuclear retention of mRNAs containing IRAlus is variable, and how regulation of retention and export is achieved is poorly understood. Here we show one mechanism of such regulation via the arginine methyltransferase CARM1 (coactivator-associated arginine methyltransferase 1). We demonstrate that disruption of CARM1 enhances the nuclear retention of mRNAs containing IRAlus. CARM1 regulates this nuclear retention pathway at two levels: CARM1 methylates the coiled-coil domain of p54(nrb), resulting in reduced binding of p54(nrb) to mRNAs containing IRAlus, and also acts as a transcription regulator to suppress NEAT1 transcription, leading to reduced paraspeckle formation. These actions of CARM1 work together synergistically to regulate the export of transcripts containing IRAlus from paraspeckles under certain cellular stresses, such as poly(I:C) treatment. This work demonstrates how a post-translational modification of an RNA-binding protein affects protein-RNA interaction and also uncovers a mechanism of transcriptional regulation of the long noncoding RNA NEAT1.


Subject(s)
Cell Nucleus/metabolism , Protein-Arginine N-Methyltransferases/metabolism , RNA, Long Noncoding/metabolism , RNA, Messenger/metabolism , Alu Elements/genetics , Animals , Cell Line , DNA Methylation , Gene Expression Regulation , HEK293 Cells , HeLa Cells , Humans , Inverted Repeat Sequences/genetics , Mice , Protein Binding , Protein Processing, Post-Translational , Protein Transport
11.
Cell Res ; 25(4): 459-76, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25708366

ABSTRACT

Adenosine deaminases acting on RNA (ADARs) are involved in adenosine-to-inosine RNA editing and are implicated in development and diseases. Here we observed that ADAR1 deficiency in human embryonic stem cells (hESCs) significantly affected hESC differentiation and neural induction with widespread changes in mRNA and miRNA expression, including upregulation of self-renewal-related miRNAs, such as miR302s. Global editing analyses revealed that ADAR1 editing activity contributes little to the altered miRNA/mRNA expression in ADAR1-deficient hESCs upon neural induction. Genome-wide iCLIP studies identified that ADAR1 binds directly to pri-miRNAs to interfere with miRNA processing by acting as an RNA-binding protein. Importantly, aberrant expression of miRNAs and phenotypes observed in ADAR1-depleted hESCs upon neural differentiation could be reversed by an enzymatically inactive ADAR1 mutant, but not by the RNA-binding-null ADAR1 mutant. These findings reveal that ADAR1, but not its editing activity, is critical for hESC differentiation and neural induction by regulating miRNA biogenesis via direct RNA interaction.


Subject(s)
Adenosine Deaminase/genetics , Cell Differentiation/genetics , MicroRNAs/biosynthesis , RNA-Binding Proteins/genetics , Adenosine Deaminase/metabolism , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Humans , MicroRNAs/genetics , Neurons/metabolism , Neurons/physiology , RNA Editing/genetics , RNA Processing, Post-Transcriptional/genetics , RNA-Binding Proteins/metabolism
12.
Cell Res ; 24(5): 513-31, 2014 May.
Article in English | MEDLINE | ID: mdl-24662484

ABSTRACT

The human 8q24 gene desert contains multiple enhancers that form tissue-specific long-range chromatin loops with the MYC oncogene, but how chromatin looping at the MYC locus is regulated remains poorly understood. Here we demonstrate that a long noncoding RNA (lncRNA), CCAT1-L, is transcribed specifically in human colorectal cancers from a locus 515 kb upstream of MYC. This lncRNA plays a role in MYC transcriptional regulation and promotes long-range chromatin looping. Importantly, the CCAT1-L locus is located within a strong super-enhancer and is spatially close to MYC. Knockdown of CCAT1-L reduced long-range interactions between the MYC promoter and its enhancers. In addition, CCAT1-L interacts with CTCF and modulates chromatin conformation at these loop regions. These results reveal an important role of a previously unannotated lncRNA in gene regulation at the MYC locus.


Subject(s)
Chromatin/metabolism , Colorectal Neoplasms/genetics , Gene Expression Regulation, Neoplastic , Proto-Oncogene Proteins c-myc/genetics , RNA, Long Noncoding/genetics , CCCTC-Binding Factor , Cell Line, Tumor , Chromatin/chemistry , Colon/metabolism , Colon/pathology , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Enhancer Elements, Genetic , Gene Knockdown Techniques , Genes, myc , Genetic Loci , Humans , Promoter Regions, Genetic , RNA, Long Noncoding/metabolism , Rectum/metabolism , Rectum/pathology , Repressor Proteins/metabolism
13.
Asian Pac J Cancer Prev ; 15(24): 10949-55, 2014.
Article in English | MEDLINE | ID: mdl-25605207

ABSTRACT

Liver cancer is one of leading digestive malignancies with high morbidity and mortality. There is an urgent need for the development of novel therapies for this deadly disease. It has been proven that asparagus polysaccharide, one of the most active derivates from the traditional medicine asparagus, possesses notable antitumor properties. However, little is known about the efficacy of asparagus polysaccharide as an adjuvant for liver cancer chemotherapy. Herein, we reported that asparagus polysaccharide and its embolic agent form, asparagus gum, significantly inhibited liver tumor growth with transcatheter arterial chemoembolization (TACE) therapy in an orthotopic hepatocellular carcinoma (HCC) tumor model, while significantly inhibiting angiogenesis and promoting tumor cell apoptosis. Moreover, asparagine gelatinous possessed immunomodulatory functions and showed little toxicity to the host. These results highlight the chemotherapeutic potential of asparagus polysaccharide and warrant a future focus on development as novel chemotherapeutic agent for liver cancer TACE therapy.


Subject(s)
Asparagus Plant/chemistry , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/prevention & control , Chemoembolization, Therapeutic , Hepatic Artery/drug effects , Neovascularization, Pathologic/prevention & control , Polysaccharides/pharmacology , Animals , Blotting, Western , Carcinoma 256, Walker/blood supply , Carcinoma 256, Walker/mortality , Carcinoma 256, Walker/pathology , Carcinoma 256, Walker/prevention & control , Carcinoma, Hepatocellular/blood supply , Carcinoma, Hepatocellular/mortality , Hepatic Artery/pathology , Humans , Liver Neoplasms/blood supply , Liver Neoplasms/mortality , Liver Neoplasms/pathology , Liver Neoplasms/prevention & control , Male , Rats , Rats, Wistar , Survival Rate , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
14.
Mol Cell ; 51(6): 792-806, 2013 Sep 26.
Article in English | MEDLINE | ID: mdl-24035497

ABSTRACT

We describe the identification and characterization of circular intronic long noncoding RNAs in human cells, which accumulate owing to a failure in debranching. The formation of such circular intronic RNAs (ciRNAs) can be recapitulated using expression vectors, and their processing depends on a consensus motif containing a 7 nt GU-rich element near the 5' splice site and an 11 nt C-rich element close to the branchpoint site. In addition, we show that ciRNAs are abundant in the nucleus and have little enrichment for microRNA target sites. Importantly, knockdown of ciRNAs led to the reduced expression of their parent genes. One abundant such RNA, ci-ankrd52, largely accumulates to its sites of transcription, associates with elongation Pol II machinery, and acts as a positive regulator of Pol II transcription. This study thus suggests a cis-regulatory role of noncoding intronic transcripts on their parent coding genes.


Subject(s)
DNA Polymerase II/genetics , RNA Polymerase II/genetics , RNA, Long Noncoding/genetics , Transcription, Genetic , Gene Knockdown Techniques , Humans , Introns/genetics , MicroRNAs/genetics , RNA Splice Sites
15.
Zhongguo Gu Shang ; 26(2): 138-41, 2013 Feb.
Article in Chinese | MEDLINE | ID: mdl-23678762

ABSTRACT

OBJECTIVE: To investigate the regulatory effect of Jingang Jiangu pill (see text, JGJG) on expression of integrin in ovariectomized rats. METHODS: Fifty ovariectomized 10 months old female rats were randomly divided into 5 groups: Fushanmei group (FSM), Jingang Jiangu pill (see text) group (JGJG), Gusongbao granule group (GSB), Model group (OVX), Sham group. After ovariectomized,the rats were raised in the same environment for 13 weeks. The rats in JGJG group took 0.13 g JGJG pill orally each day for each rat; the rats in GSB group took 0.86 g GSB granule orally each day for each rat; the rats in FSM group took 0.28 mg FSM orally each day for each rat; and the rats in OVX and sham groups took sodium. The treatment duration of rats in above 5 groups was 13 weeks. Bone mineral density (BMD) and the expression of integrin beta1 and alphavbeta3 were detected in each group after the treatment. RESYKTS: The BMD and the expression of integrin beta1 in FSM group, JGJG group and GSB group improved obviously than that of OVX group. There were statistical difference between these groups (P<0.05). The expression of integrin alphavbeta3 of the three treating groups significantly depressed. CONCLUSION: The JGJG pill improves BMD and express of integrin beta1, in ovariectomized rats and reduces express of integrin alphavbeta3 through the regulation of the coupling of osteoblasts and osteoclasts.


Subject(s)
Integrin alphaVbeta3/analysis , Integrin beta1/analysis , Medicine, Chinese Traditional , Osteoporosis/drug therapy , Animals , Bone Density , Disease Models, Animal , Female , Osteoporosis/metabolism , Ovariectomy , Rats , Rats, Wistar
16.
BMC Genomics ; 14: 206, 2013 Mar 27.
Article in English | MEDLINE | ID: mdl-23537002

ABSTRACT

BACKGROUND: Adenosine-to-inosine (A-to-I) RNA editing is recognized as a cellular mechanism for generating both RNA and protein diversity. Inosine base pairs with cytidine during reverse transcription and therefore appears as guanosine during sequencing of cDNA. Current approaches of RNA editing identification largely depend on the comparison between transcriptomes and genomic DNA (gDNA) sequencing datasets from the same individuals, and it has been challenging to identify editing candidates from transcriptomes in the absence of gDNA information. RESULTS: We have developed a new strategy to accurately predict constitutive RNA editing sites from publicly available human RNA-seq datasets in the absence of relevant genomic sequences. Our approach establishes new parameters to increase the ability to map mismatches and to minimize sequencing/mapping errors and unreported genome variations. We identified 695 novel constitutive A-to-I editing sites that appear in clusters (named "editing boxes") in multiple samples and which exhibit spatial and dynamic regulation across human tissues. Some of these editing boxes are enriched in non-repetitive regions lacking inverted repeat structures and contain an extremely high conversion frequency of As to Is. We validated a number of editing boxes in multiple human cell lines and confirmed that ADAR1 is responsible for the observed promiscuous editing events in non-repetitive regions, further expanding our knowledge of the catalytic substrate of A-to-I RNA editing by ADAR enzymes. CONCLUSIONS: The approach we present here provides a novel way of identifying A-to-I RNA editing events by analyzing only RNA-seq datasets. This method has allowed us to gain new insights into RNA editing and should also aid in the identification of more constitutive A-to-I editing sites from additional transcriptomes.


Subject(s)
Adenosine/metabolism , Genomics , Inosine/metabolism , RNA Editing , Transcriptome/genetics , Adenosine Deaminase/metabolism , Base Sequence , Biocatalysis , Cell Line , Cluster Analysis , Genome, Human/genetics , HeLa Cells , Humans , Molecular Sequence Data , Polymerase Chain Reaction , Reproducibility of Results , Sequence Analysis, RNA
17.
Mol Cell ; 48(2): 219-30, 2012 Oct 26.
Article in English | MEDLINE | ID: mdl-22959273

ABSTRACT

We describe the discovery of sno-lncRNAs, a class of nuclear-enriched intron-derived long noncoding RNAs (lncRNAs) that are processed on both ends by the snoRNA machinery. During exonucleolytic trimming, the sequences between the snoRNAs are not degraded, leading to the accumulation of lncRNAs flanked by snoRNA sequences but lacking 5' caps and 3' poly(A) tails. Such RNAs are widely expressed in cells and tissues and can be produced by either box C/D or box H/ACA snoRNAs. Importantly, the genomic region encoding one abundant class of sno-lncRNAs (15q11-q13) is specifically deleted in Prader-Willi Syndrome (PWS). The PWS region sno-lncRNAs do not colocalize with nucleoli or Cajal bodies, but rather accumulate near their sites of synthesis. These sno-lncRNAs associate strongly with Fox family splicing regulators and alter patterns of splicing. These results thus implicate a previously unannotated class of lncRNAs in the molecular pathogenesis of PWS.


Subject(s)
Prader-Willi Syndrome , RNA Splicing/genetics , RNA, Long Noncoding , RNA, Small Nucleolar , Base Sequence , Cell Line , Cell Nucleolus/genetics , Cell Nucleolus/metabolism , Coiled Bodies/genetics , Coiled Bodies/metabolism , Gene Expression Regulation , Humans , Introns , Molecular Sequence Data , Prader-Willi Syndrome/genetics , Prader-Willi Syndrome/metabolism , RNA Splicing Factors , RNA, Long Noncoding/genetics , RNA, Long Noncoding/metabolism , RNA, Small Nucleolar/genetics , RNA, Small Nucleolar/metabolism , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL